SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001730463-21-000008
Filing Date
2021-05-06
Accepted
2021-05-06 16:05:01
Documents
70
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 6-K autl-20210331_d2.htm   iXBRL 6-K 24353
2 EX-99.1 autl-20210331.htm   iXBRL EX-99.1 797479
3 EX-99.2 exhibit992-operatingresult.htm EX-99.2 155031
  Complete submission text file 0001730463-21-000008.txt   4918592

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT autl-20210331.xsd EX-101.SCH 40365
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT autl-20210331_cal.xml EX-101.CAL 62931
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT autl-20210331_def.xml EX-101.DEF 217209
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT autl-20210331_lab.xml EX-101.LAB 457028
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT autl-20210331_pre.xml EX-101.PRE 341302
9 EXTRACTED XBRL INSTANCE DOCUMENT autl-20210331_d2_htm.xml XML 674906
Mailing Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ
Business Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38547 | Film No.: 21897654
SIC: 2836 Biological Products, (No Diagnostic Substances)